Skip to the page

Data / Form D filings / Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.: Form D filings

Mind Medicine (MindMed) Inc., a pharmaceuticals company in New York, NY, filed 6 Form D notices with the SEC between 2020 and 2025. The latest, on May 5, 2025, reports $7 million sold of a $7 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
One World Trade Center, Suite 8500, New York, NY, 10007
Phone
(212) 220-6633
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1813814

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 5, 2025New notice$7,000,000$7,000,0001Aug 11, 2023sec.gov
Mar 18, 2024New notice$75,000,000$75,000,0002Mar 11, 2024sec.gov
Jan 20, 2021New notice$826,073$499,618$326,4551Jan 6, 2021sec.gov
Dec 22, 2020New notice$128,730$78,268$50,4621Dec 11, 2020sec.gov
Nov 13, 2020New notice$412,842$247,705$165,1371Oct 30, 2020sec.gov
Jun 8, 2020New notice$468,248$468,2482May 22, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Carrie LiaoExecutive Officer
Suzanne R. BruhnDirector
Carol A. ValloneDirector
Mark R. SullivanExecutive Officer
Andreas R. KrebsDirector
Matt WileyExecutive Officer
Robert BarrowDirector, Executive Officer
Roger R. CrystalDirector
David A. GryskaDirector
Daniel KarlinExecutive Officer

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of May 5, 2025 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Mind Medicine (MindMed) Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.